In those without GRN mutations, plasma PGRN concentrations were significantly higher than controls in multiple groups (Fig. 3A), including not only those with FTD syndromes, but also those with typical and atypical forms of Alzheimer’s disease (including posterior cortical atrophy). The gene discussed is GRN; the disease is early-onset autosomal dominant Alzheimer disease.